Related Experiment Videos
Classification and staging of melanoma
J E Gershenwald1, A C Buzaid, M I Ross
1Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA.
Clinics in Laboratory Medicine
|February 28, 2001
Summary
Developing a melanoma staging system is challenging due to the cancer's variable behavior. Current AJCC staging is evolving, incorporating new prognostic factors and re-evaluating existing criteria for better patient assessment and treatment planning.
Area of Science:
- Oncology
- Dermatology
- Medical Staging
Background:
- Standardized cancer staging is crucial for comparing patient outcomes.
- Melanoma's unpredictable biology complicates staging system development.
- Previous staging systems have been sequentially modified based on new prognostic factors.
Purpose of the Study:
- To review current challenges and controversies in cutaneous melanoma staging.
- To propose stage-specific recommendations for assessing disease extent.
- To provide a framework for efficient and cost-conscious clinical practice.
Main Methods:
- Review of existing literature on melanoma prognostic factors.
- Analysis of current American Joint Committee on Cancer (AJCC) staging criteria.
- Discussion of controversial staging elements like tumor thickness, ulceration, and nodal involvement.
- Outline of recommended diagnostic work-ups for different melanoma stages (I-IV).
Main Results:
- Several prognostic factors (e.g., invasion depth, ulceration, nodal status) remain debated in melanoma staging.
- Current AJCC staging incorporates well-established factors but is subject to ongoing refinement.
- Recommended staging work-ups vary by stage, from basic blood tests and imaging for early stages to comprehensive evaluations for advanced disease.
- Techniques like sentinel lymph node biopsy are crucial for staging regional disease.
Conclusions:
- Melanoma staging requires continuous evolution to incorporate new prognostic insights.
- Stage-specific diagnostic recommendations aid in efficient disease assessment.
- Future staging systems will likely integrate more complex prognostic factors for improved accuracy.